tiprankstipranks
Trending News
More News >

Anicom Holdings Reports Growth in Pet Insurance and Advances in Regenerative Medicine

Story Highlights
Anicom Holdings Reports Growth in Pet Insurance and Advances in Regenerative Medicine

The latest announcement is out from Anicom Holdings, Inc. ( (JP:8715) ).

Anicom Holdings, Inc. has released its monthly management parameters for February 2025, highlighting its progress in the pet insurance sector and new business initiatives. The company reported an increase in net premiums written and the number of policies in force compared to the previous year. Additionally, Anicom is advancing its regenerative medicine business through the Research and Development Partnership for Animal Regenerative Medicine (PARM), which aims to standardize cell therapy services for domestic animals. The company is also promoting its BioInsurTech initiatives, focusing on preventing injuries and illnesses using big data.

More about Anicom Holdings, Inc.

Anicom Holdings, Inc. operates in the pet insurance industry, focusing on providing insurance services for pets. The company is also involved in new business initiatives aimed at becoming a prevention-oriented company, with a particular emphasis on gut microbiota testing and regenerative medicine for animals.

YTD Price Performance: -18.63%

Average Trading Volume: 375,414

Technical Sentiment Consensus Rating: Buy

Current Market Cap: Yen42.82B

Learn more about 8715 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App